242 related articles for article (PubMed ID: 33910573)
1. Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications.
Kwok WC; Ho JCM; Tam TCC; Ip MSM; Lam DCL
Respir Res; 2021 Apr; 22(1):132. PubMed ID: 33910573
[TBL] [Abstract][Full Text] [Related]
2. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
[TBL] [Abstract][Full Text] [Related]
3. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
[TBL] [Abstract][Full Text] [Related]
4.
Wang H; Ji XB; Mao B; Li CW; Lu HW; Xu JF
BMJ Open; 2018 Mar; 8(3):e014613. PubMed ID: 29540404
[TBL] [Abstract][Full Text] [Related]
5. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
Venning V; Bartlett J; Jayaram L
Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
[TBL] [Abstract][Full Text] [Related]
6. Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis.
Pieters A; Bakker M; Hoek RAS; Altenburg J; van Westreenen M; Aerts JGJV; van der Eerden MM
Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2299-2304. PubMed ID: 31471703
[TBL] [Abstract][Full Text] [Related]
7. Sputum Exosomal microRNAs Profiling Reveals Critical Pathways Modulated By
Huang Y; Chen CL; Yuan JJ; Li HM; Han XR; Chen RC; Guan WJ; Zhong NS
Int J Chron Obstruct Pulmon Dis; 2019; 14():2563-2573. PubMed ID: 31819394
[TBL] [Abstract][Full Text] [Related]
8. Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.
Suarez-Cuartin G; Giner J; Merino JL; Rodrigo-Troyano A; Feliu A; Perea L; Sanchez-Reus F; Castillo D; Plaza V; Chalmers JD; Sibila O
Respir Med; 2018 Mar; 136():111-117. PubMed ID: 29501241
[TBL] [Abstract][Full Text] [Related]
9. Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis.
Alcaraz-Serrano V; Fernández-Barat L; Scioscia G; Llorens-Llacuna J; Gimeno-Santos E; Herrero-Cortina B; Vàzquez N; Puig de la Bellacasa J; Gabarrús A; Amaro-Rodriguez R; Menéndez R; Torres A
Respir Med; 2019; 154():40-46. PubMed ID: 31212120
[TBL] [Abstract][Full Text] [Related]
10. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
[TBL] [Abstract][Full Text] [Related]
11.
Taylor SL; Woodman RJ; Chen AC; Burr LD; Gordon DL; McGuckin MA; Wesselingh S; Rogers GB
Thorax; 2017 Apr; 72(4):304-310. PubMed ID: 27503233
[TBL] [Abstract][Full Text] [Related]
12. How does Pseudomonas aeruginosa affect the progression of bronchiectasis?
Chai YH; Xu JF
Clin Microbiol Infect; 2020 Mar; 26(3):313-318. PubMed ID: 31306794
[TBL] [Abstract][Full Text] [Related]
13. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.
Valderrey AD; Pozuelo MJ; Jiménez PA; Maciá MD; Oliver A; Rotger R
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):20-7. PubMed ID: 20727465
[TBL] [Abstract][Full Text] [Related]
14. Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with
Tanriverdi E; Yildirim BZ; Gul S; Chousein EGU; Turan D; Çınarka H; Özgül MA; Cetinkaya E
J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):274-279. PubMed ID: 33351705
[No Abstract] [Full Text] [Related]
15. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis.
Cios K; Cohen B; Quittell LM; Liu J; Larson EL
Am J Infect Control; 2019 Jul; 47(7):750-754. PubMed ID: 30732978
[TBL] [Abstract][Full Text] [Related]
16. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Bilton D; Henig N; Morrissey B; Gotfried M
Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.
Hirama T; Tomiyama F; Notsuda H; Watanabe T; Watanabe Y; Oishi H; Okada Y
BMC Pulm Med; 2021 Aug; 21(1):261. PubMed ID: 34384425
[TBL] [Abstract][Full Text] [Related]
18. [Clinical implication and management of Pseudomonas aeruginosa colonization in patients with bronchiectasis].
Xu JF; Chai YH
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jul; 42(7):506-509. PubMed ID: 31365966
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis.
Finch S; McDonnell MJ; Abo-Leyah H; Aliberti S; Chalmers JD
Ann Am Thorac Soc; 2015 Nov; 12(11):1602-11. PubMed ID: 26356317
[TBL] [Abstract][Full Text] [Related]
20. The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.
Martínez-García MÁ; Vendrell M; Girón R; Máiz-Carro L; de la Rosa Carrillo D; de Gracia J; Olveira C
Ann Am Thorac Soc; 2016 Sep; 13(9):1468-75. PubMed ID: 27348199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
